Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Jun 23;1152:122254. doi: 10.1016/j.jchromb.2020.122254

Fig.4.

Fig.4.

Silmitasertib plasma concentration-time profile for a pediatric patient after administration of single and repeated oral doses of silmitasertib (1,000 mg twice a day). Observed and model-predicted data after single dose are shown by circles and dotted line, respectively. Observed and model-predicted data after repeated doses are shown by squares and dashed line, respectively.